Home study versus in-lab justification
Many payers require a home sleep apnea test first and will deny in-lab polysomnography without documented justification for the higher level of testing.
Specialties › Sleep Medicine
Sleep medicine revenue has two halves that fail in different ways. Testing fails on authorization and on payers insisting a home study was appropriate instead of an in-lab study. Device and supply revenue fails on compliance documentation — continued CPAP coverage depends on proving the patient actually uses the device, and practices that do not track that lose recurring revenue months after the sale.
These are the issues that repeat every month in sleep medicine practices — and the ones we fix at the source rather than reworking claim by claim.
Many payers require a home sleep apnea test first and will deny in-lab polysomnography without documented justification for the higher level of testing.
Sleep studies are commonly authorized in advance, and the authorization must match the study type actually performed. Converting a diagnostic study to a titration mid-night can break the authorization.
Continued coverage of a device and its supplies depends on documented adherence within the required window. Missing compliance data ends the revenue stream and can trigger recoupment.
Masks, cushions, tubing and filters have defined replacement intervals. Billing early denies; never billing at all silently forfeits predictable recurring revenue.
In-lab studies involve a technical component and a professional interpretation that may be billed by different entities, requiring correct component reporting.
Listed for context only — this is not billing advice, and payer policy varies. Our certified coders work to AAPC and AHIMA standards.
We root-cause denials by payer and procedure, then fix the upstream workflow so the same denial stops recurring.
Your account is worked by people who bill sleep medicine every day — not a general pool learning your rules on your claims.
Relentless follow-up on every claim, with aged A/R worked rather than written off.
Performance-based pricing — a percentage of what we collect. Stay because the results are good, not because you are locked in.
We run parallel with your current process until the transition is verifiably clean.
Our certified coders work every claim; AI tools help them catch more before submission.
Strict PHI controls, access limits and staff training across the whole workflow.
Yes, and they are very different workflows. Testing is authorization-driven; devices and supplies are compliance- and interval-driven. Practices usually need both handled properly to capture the full revenue.
Yes. Adherence documentation within the required window determines whether the device and its ongoing supplies stay covered. We track it rather than discovering it at recoupment.
Yes. We bill independent diagnostic testing facilities and hospital-affiliated labs, applying the correct technical and professional component reporting for each arrangement.
Yes. Home study denials usually trace to authorization mismatches or diagnosis coding rather than the study itself. Our A/R analysis identifies the pattern before you write more off.
★★★★★Our A/R days dropped from 58 to 31 in one quarter. First time in years I actually trust my numbers.
— Sarah M., Practice Manager
★★★★★Denials were killing us. First-pass acceptance went up fast, and they tell us why a claim failed — not just rework it quietly.
— Michael R., Billing Lead
A no-obligation A/R analysis. We review your aging, denial patterns and coding mix, then show you exactly where the recoverable revenue is.
Other specialties: Mental Health & Behavioral Health Cardiology Physical Therapy Pain Management Orthopedics · see all